Contact Us marketing@medicilon.com
CN
×
Close Button
Medicilon's News information
News information

Join Medicilon Dinner during ISSX 2024

2024-08-13
|
Page View:

1.jpg

26th North American ISSX and 39th JSSX Meeting kicks off on September 15-18 in Honolulu. We are excited to invite you to visit us at Medicilon Booth #104. Our Science and Business teams are looking forward to meeting you.

Medicilon will host a dinner party during this conference. We sincerely invite you to attend.

Date: September 16, 2024 (Monday)

Time: 19:00-21:00

Location: Roy's Waikiki (226 Lewers St Honolulu, HI 96815) 

Organizer: Medicilon

Meet with Medicilon
Subject丨Medicilon Dinner

About  Medicilon

Medicilon is a global integrated pharmaceutical R&D service contract research organization (CRO), providing a full range of one-stop preclinical R&D services, in compliance with Chinese and international regulatory filing standards, to pharmaceutical companies and research institutions world-wide. With our experience in serving domestic and foreign biomedical industries, we have built an integrated platform covering key technologies in drug discovery, pharmaceutical research, and preclinical research, to provide a comprehensive preclinical R&D service for the global biomedical industry.

20 Years of Excellence

500+ INDs Approved by FDA, NMPA, EMA, and TGA

2000+ Active Clients Worldwide

2600+ Scientists & Research Staff

85,000+ m2 Lab Space

At Medicilon, we are dedicated to support our clients develop their research and discovery programs from initial concept through the IND filing phase. Our services span across medicinal chemistry, biology, API, CMC, formulation, and preclinical studies. We provide flexible business models, including stand-alone Fee for Services (FFS) and fully integrated FTE services. In addition, our facilities are GLP/GMP compliant, US-FDA, China NMPA and AAALAC accredited. All study reports can be presented in SEND format, supporting dual filing of IND applications in the US, EU, and China.

Share:
Return
Relevant newsOnline registration
Company*
Name*
Work Email*
Title*
Verification Code*
Click to switch
Relevant newsRelevant news